DiscoverThe Lancet in conversation withRebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus
Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Update: 2025-07-24
Share

Description

Early detection of oesophageal adenocarcinoma improves outcomes. Patients with the precursor lesion, Barrett's oesophagus, are recommended to undergo regular endoscopic surveillance, a process that can be burdensome for patients and health services. 

Professor Rebecca Fitzgerald's team have developed a tool that may be able to improve Barrett's surveillance. She joins us to discuss her recent prospective real-world implementation study of capsule sponge risk stratification in Barrett’s oesophagus surveillance in the UK.

Read the full article:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01021-9/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lancet

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
ASCO 2025 Debrief

ASCO 2025 Debrief

2025-06-1115:14

Previewing ASCO 2025

Previewing ASCO 2025

2025-05-3005:24

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

The Lancet Group